Advanced Biomed Inc. (ADVB)
NASDAQ: ADVB · Real-Time Price · USD
4.460
+0.390 (9.58%)
At close: Mar 6, 2026, 4:00 PM EST
4.220
-0.240 (-5.38%)
After-hours: Mar 6, 2026, 7:42 PM EST
Advanced Biomed Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Selling, General & Admin | 2.35 | 2.11 | 1.66 | 1.69 | 0.75 | 0.1 |
| Research & Development | 0.95 | 0.91 | 0.88 | 1.38 | 1.62 | 1.73 |
| Operating Expenses | 3.3 | 3.02 | 2.54 | 3.07 | 2.37 | 1.84 |
| Operating Income | -3.3 | -3.02 | -2.54 | -3.07 | -2.37 | -1.84 |
| Interest & Investment Income | 0.02 | 0.02 | 0.05 | 0.02 | 0 | 0 |
| Currency Exchange Gain (Loss) | 0.02 | -0.23 | -0.29 | -0.51 | - | - |
| Other Non Operating Income (Expenses) | -0.03 | -0.03 | 0 | -0.02 | -0.04 | -0 |
| EBT Excluding Unusual Items | -3.3 | -3.26 | -2.78 | -3.58 | -2.41 | -1.84 |
| Impairment of Goodwill | - | - | - | - | -1.62 | - |
| Gain (Loss) on Sale of Assets | 7.35 | - | - | -0.15 | - | - |
| Pretax Income | 4.05 | -3.26 | -2.78 | -3.73 | -4.03 | -1.84 |
| Net Income | 4.39 | -3.26 | -2.78 | -3.73 | -4.03 | -1.84 |
| Net Income to Common | 4.39 | -3.26 | -2.78 | -3.73 | -4.03 | -1.84 |
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 |
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 |
| Shares Change (YoY) | 6.73% | 2.63% | 0.32% | 40.55% | 23.74% | - |
| EPS (Basic) | 4.11 | -3.18 | -2.78 | -3.74 | -5.68 | -3.21 |
| EPS (Diluted) | 4.11 | -3.18 | -2.78 | -3.74 | -5.68 | -3.21 |
| Free Cash Flow | -6.11 | -5.86 | -2.2 | -3.17 | -1.63 | -0.5 |
| Free Cash Flow Per Share | -5.73 | -5.71 | -2.20 | -3.19 | -2.30 | -0.87 |
| EBITDA | -2.97 | -2.68 | -2.14 | -2.84 | -2.26 | -1.78 |
| D&A For EBITDA | 0.33 | 0.34 | 0.4 | 0.23 | 0.11 | 0.06 |
| EBIT | -3.3 | -3.02 | -2.54 | -3.07 | -2.37 | -1.84 |
Source: S&P Capital IQ. Standard template.
Financial Sources.